ClinicalTrials.Veeva

Menu
R

RCMed | Sochaczew, Poland

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

MK-7264
Gefapixant
Olokizumab
RGB-14-P
MK-7264-030
MK-7264-043
Evobrutinib
Pirepemat
ACU193
Prolia®

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 12 total trials

A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)

This is a Phase 2b study investigating the efficacy and safety of pirepemat as adjunct therapy on falls frequency in patients with Parkinson disease....

Enrolling
Parkinson Disease
Drug: Pirepemat
Drug: Placebo

The primary purpose of this study is to evaluate the efficacy of ACU193 infusions administered once every four weeks (Q4W) in slowing cognitive and f...

Enrolling
Alzheimer Disease
Drug: ACU193
Drug: Placebo

Trial sponsors

Merck Sharp & Dohme (MSD) logo
R-Pharm logo
A
G
G
IBSA logo
I
Merck KGaA (EMD Serono) logo
Pfizer logo
Sandoz logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems